Details for New Drug Application (NDA): 090258
✉ Email this page to a colleague
The generic ingredient in ALENDRONATE SODIUM is alendronate sodium. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the alendronate sodium profile page.
Summary for 090258
| Tradename: | ALENDRONATE SODIUM |
| Applicant: | Hangzhou Binjiang |
| Ingredient: | alendronate sodium |
| Patents: | 0 |
Suppliers and Packaging for NDA: 090258
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ALENDRONATE SODIUM | alendronate sodium | TABLET;ORAL | 090258 | ANDA | Marlex Pharmaceuticals, Inc. | 10135-718 | 10135-718-12 | 3 BLISTER PACK in 1 CARTON (10135-718-12) / 4 TABLET in 1 BLISTER PACK |
| ALENDRONATE SODIUM | alendronate sodium | TABLET;ORAL | 090258 | ANDA | Marlex Pharmaceuticals, Inc. | 10135-718 | 10135-718-44 | 1 BLISTER PACK in 1 CARTON (10135-718-44) / 4 TABLET in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE | ||||
| Approval Date: | Sep 24, 2009 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
| Approval Date: | Sep 24, 2009 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 35MG BASE | ||||
| Approval Date: | Sep 24, 2009 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
